Psychedelic Clinical Trials

271 record(s) found.

Filters: Condition: depression

Entheogen: ketamine
Study Title: Ketamine for OUD and Comorbid Depression (OUDCD)
Start Date: Feb 01, 2022 - Last Update: September 28, 2021
Conditions: Opioid-use Disorder, Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A randomised controlled feasibility study of ketamine-assisted therapy: Does fractal priming improve treatment response in treatment-resistant depression?
Start Date: Dec 07, 2021
Conditions: treatment-resistant depression
Location(s): New Zealand, Auckland Region
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Preoperative Ketamine and Perioperative Depression
Start Date: Dec 01, 2021 - Last Update: September 2, 2021
Conditions: Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Versus Midazolam for Recurrence of Suicidality in Adolescents
Start Date: Nov 01, 2021 - Last Update: July 22, 2021
Conditions: Suicide, Attempted, Suicide and Depression, Suicide Threat
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets
Start Date: Nov 01, 2021 - Last Update: September 16, 2021
Conditions: Major Depressive Disorder, Healthy Controls
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Long-term Observation of Participants With Mood Disorders
Start Date: Oct 11, 2021 - Last Update: October 6, 2021
Conditions: Depression, Suicide Risk
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Treatment-Resistant Depression
Start Date: Oct 01, 2021 - Last Update: September 5, 2021
Conditions: Treatment Resistant Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression
Start Date: Oct 01, 2021 - Last Update: September 28, 2021
Conditions: Treatment-resistant Depression, Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
Start Date: Sep 27, 2021 - Last Update: September 29, 2021
Conditions: Depressive Disorder, Treatment-Resistant
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Repeated Neurocognitive Measurements in Depressed Patients
Start Date: Sep 16, 2021 - Last Update: September 23, 2021
Conditions: Depression, Unipolar
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
Start Date: Sep 15, 2021 - Last Update: August 26, 2021
Conditions: Anxiety and Depression
Location(s): Jamaica
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as an Adjunctive Therapy for Major Depression (2)
Start Date: Sep 13, 2021 - Last Update: September 16, 2021
Conditions: Major Depressive Episode, Unipolar Depression, Bipolar Depression
Location(s): Ireland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effectiveness of Ketamine Treatment for Three Consecutive Days in Depression
Start Date: Sep 01, 2021 - Last Update: August 30, 2021
Conditions: Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
Start Date: Aug 15, 2021 - Last Update: September 5, 2021
Conditions: Parkinson Disease, Depression, Anxiety
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for the Treatment of Depression in Parkinson's Disease
Start Date: Aug 01, 2021 - Last Update: June 29, 2021
Conditions: Parkinson's Disease, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Psychological and Existential Distress in Palliative Care
Start Date: Aug 01, 2021 - Last Update: April 1, 2021
Conditions: Depression, Anxiety, Distress, Emotional
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Single Ketamine Infusion Combined With Music for Suicidal Ideation
Start Date: Jul 01, 2021 - Last Update: May 7, 2021
Conditions: Suicidal Ideation, Depressive Episode
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: D-serine Supplementation for Depression
Start Date: Jul 01, 2021 - Last Update: July 28, 2021
Conditions: Major Depressive Disorder
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
Start Date: Jun 10, 2021 - Last Update: July 29, 2021
Conditions: Treatment-resistant Depression
Location(s): Germany
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Esketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive Disorder
Start Date: May 01, 2021 - Last Update: April 19, 2021
Conditions: Chronic Visceral Pain, Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Safety and Efficacy Evaluation of S (+) - Ketamine in Children
Start Date: May 01, 2021 - Last Update: April 8, 2021
Conditions: S-ketamine, Esketamine, Acute Pain, Postoperative Pain, Analgesia, Hyperalgesia, Delirium, Depression, Anxiety, Children
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
Start Date: Apr 14, 2021 - Last Update: April 15, 2021
Conditions: Major Depressive Disorder, Alcohol Use Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Reward Emotion Learning and Ketamine Study
Start Date: Apr 01, 2021 - Last Update: April 20, 2021
Conditions: Depression, Major Depressive Disorder, Treatment Resistant Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
Start Date: Mar 24, 2021 - Last Update: March 26, 2021
Conditions: Depressive Symptoms, Depression, Alzheimer Disease, Mild Cognitive Impairment
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
Start Date: Mar 17, 2021 - Last Update: May 17, 2021
Conditions: Major Depressive Disorder, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
Start Date: Mar 01, 2021 - Last Update: March 3, 2021
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
Start Date: Mar 01, 2021 - Last Update: March 3, 2021
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Esketamine and Perioperative Depressive Symptoms
Start Date: Feb 19, 2021 - Last Update: March 2, 2021
Conditions: Depressive Symptoms, Esketamine, Perioperative Complication, Major Surgery
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer
Start Date: Feb 10, 2021 - Last Update: April 20, 2021
Conditions: Depression
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients
Start Date: Feb 04, 2021 - Last Update: September 14, 2021
Conditions: Major Depressive Disorder
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Oral Ketamine Trial on Adults with Treatment-Resistant Depression
Start Date: Feb 03, 2021
Conditions: Treatment-Resistant Depression
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Pharmacogenetics Associated With IV Ketamine
Start Date: Jan 21, 2021 - Last Update: August 18, 2021
Conditions: Treatment Resistant Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression
Start Date: Jan 11, 2021 - Last Update: August 23, 2021
Conditions: Depressive Disorder, Treatment-Resistant, Depressive Disorder, Major, Unipolar Depression, Depression, Bipolar
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: A randomised, double-blind, placebo-controlled trial of repeated microdoses of lysergic acid diethylamide (LSD) in healthy volunteers
Start Date: Jan 05, 2021
Conditions: Major depressive disorder
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: IM Ketamine vs Midazolam for Suicidal ER Patients
Start Date: Jan 02, 2021 - Last Update: February 21, 2021
Conditions: Depression, Unipolar, Depression, Bipolar, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
Start Date: Jan 01, 2021 - Last Update: December 19, 2020
Conditions: Major Depressive Disorder, Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for the Treatment of Opioid Use Disorder and Depression
Start Date: Dec 17, 2020 - Last Update: January 11, 2021
Conditions: Depression, Opioid-use Disorder, Opioid Abuse
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
Start Date: Dec 17, 2020 - Last Update: January 22, 2021
Conditions: Depressive Disorder, Major, Suicidal
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The Efficacy and Safety of S-ketamine in Elective Cesarean Section
Start Date: Dec 01, 2020 - Last Update: December 8, 2020
Conditions: Anesthesia, Analgesia, Depression, Cesarean Section, Parturition
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Use of Transmucosal Ketamine in Post Stroke Depression
Start Date: Nov 30, 2020 - Last Update: May 6, 2021
Conditions: Post-stroke Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine to Prevent PPD After Cesarean
Start Date: Nov 12, 2020 - Last Update: November 17, 2020
Conditions: Postpartum Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: University of Iowa Interventional Psychiatry Service Patient Registry
Start Date: Nov 02, 2020 - Last Update: April 8, 2021
Conditions: Treatment Resistant Depression, Major Depressive Episode, Major Depression, Major Depressive Disorder, Bipolar Disorder, Bipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Older Adults Pilot
Start Date: Oct 22, 2020 - Last Update: August 18, 2021
Conditions: Treatment Resistant Depression, Refractory Depression, Therapy-Resistant Depression, Late Life Depression, Geriatric Depression
Location(s): United States, Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Treatment Effects on Synaptic Plasticity in Depression
Start Date: Oct 09, 2020 - Last Update: May 7, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Imaging Neural Correlates of Ketamine Using PET/MR
Start Date: Oct 01, 2020 - Last Update: October 14, 2020
Conditions: Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
Start Date: Sep 15, 2020 - Last Update: September 27, 2021
Conditions: Treatment Resistant Depression
Location(s): United States, Ireland
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Start Date: Sep 01, 2020 - Last Update: October 20, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin in Depression Resistant to Standard Treatments
Start Date: Sep 01, 2020 - Last Update: July 22, 2021
Conditions: Treatment Resistant Depression
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A randomised, placebo controlled trial of psilocybin in treatment resistant depression: A feasibility study
Start Date: Aug 27, 2020
Conditions: Major depressive disorder
Location(s): United Kingdom(United Kingdom, -, no, longer, in, EU/EstoniaA)
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Behavioral and Electrophysiological Effects of Ketamine in Treatment-Resistant Depression
Start Date: Aug 17, 2020 - Last Update: August 4, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Opiate Suicide Study in Patients With Major Depression
Start Date: Aug 01, 2020 - Last Update: August 31, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT)
Start Date: Aug 01, 2020 - Last Update: July 22, 2020
Conditions: Depression, Bipolar, Depression, Unipolar, Major Depressive Disorder, Manic-Depressive - Now Depressed
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)
Start Date: Jul 20, 2020 - Last Update: March 3, 2021
Conditions: Treatment Resistant Depression
Location(s): United States, Czechia, Ireland, Netherlands, United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A multicentre study to assess safety and efficacy of psilocybin in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)
Start Date: Jul 08, 2020
Conditions: Treatment-Resistant Depression (P-TRD)
Location(s): Portugal, Czech Republic, Denmark, Netherlands, Germany
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Start Date: Jun 30, 2020 - Last Update: September 30, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low Dose Ketamine Infusion for the Treatment of Resistant Depression
Start Date: Jun 29, 2020 - Last Update: May 1, 2020
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low-dose S-ketamine in Women With Prenatal Depression
Start Date: Jun 19, 2020 - Last Update: July 12, 2021
Conditions: Prenatal Depression, Ketamine, Postpartum Depression
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression
Start Date: Jun 19, 2020 - Last Update: September 16, 2021
Conditions: Perinatal Depression, Ketamine, Postpartum Depression
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intravenous Ketamine Effects on Functional Neuroanatomy
Start Date: May 02, 2020 - Last Update: June 1, 2020
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)
Start Date: May 01, 2020 - Last Update: April 20, 2020
Conditions: Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study in healthy volunteers of the safety and how the body handles PCN-101
Start Date: Mar 03, 2020
Conditions: Depression
Location(s): New Zealand, Auckland, United States of America
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
Start Date: Jan 21, 2020 - Last Update: March 11, 2021
Conditions: Depression, Major Depressive Disorder, Major Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department
Start Date: Jan 14, 2020 - Last Update: March 2, 2021
Conditions: Suicide, Suicide Threat, Depression Severe
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Interleaved With Electroconvulsive Therapy for Depression
Start Date: Jan 06, 2020 - Last Update: September 9, 2021
Conditions: Depression
Location(s): Ireland
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: The Effect of 3, 4-Methylenedioxymethamphetamine (MDMA)-assisted therapy on Mood and Anxiety symptoms in advanced-stage Cancer Study
Start Date: Jan 06, 2020
Conditions: Depression symptoms, Anxiety symptoms, Advanced-stage cancer
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: A Naturalistic Study of Ketamine for Treatment Resistant Mood Disorders
Start Date: Dec 04, 2019 - Last Update: January 13, 2020
Conditions: Treatment Resistant Depression, Bipolar Depression, Ketamine, Major Depressive Disorder
Location(s): Poland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Chart Review of Patients Undergoing Ketamine Infusions
Start Date: Dec 03, 2019 - Last Update: December 24, 2020
Conditions: Major Depressive Disorder, Bipolar Disorder, Obsessive-Compulsive Disorder, Post Traumatic Stress Disorder
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Single-dose Ketamine for the Reduction of Pain and Depression in the Emergency Department
Start Date: Dec 01, 2019 - Last Update: February 11, 2020
Conditions: Acute Pain, Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation
Start Date: Dec 01, 2019 - Last Update: September 8, 2021
Conditions: Bipolar Depression, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality
Start Date: Dec 01, 2019 - Last Update: September 27, 2019
Conditions: Treatment Resistant Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine or Placebo in Patients With Major Depression and Advanced Cancer
Start Date: Nov 19, 2019 - Last Update: August 23, 2021
Conditions: Major Depressive Disorder, Advanced Cancer
Location(s): Mexico
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: Clinical Study of GH001 in Depression
Start Date: Nov 12, 2019 - Last Update: January 7, 2021
Conditions: Treatment Resistant Depression, Major Depressive Disorder, Depression
Location(s): Netherlands
Source: clinicaltrials.gov
short summary

Entheogen: lysergic acid diethylamide
Study Title: LSD Therapy for Persons Suffering From Major Depression
Start Date: Nov 01, 2019 - Last Update: February 9, 2021
Conditions: Major Depressive Disorder
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects
Start Date: Oct 24, 2019 - Last Update: April 29, 2021
Conditions: Depression
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
Start Date: Oct 18, 2019 - Last Update: September 1, 2020
Conditions: Depression, Depression Severe, Depression Acute, Depression and Suicide, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: A Study of Psilocybin for Major Depressive Disorder (MDD)
Start Date: Oct 15, 2019 - Last Update: September 30, 2021
Conditions: Depressive Disorder, Major
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine to Improve Recovery After Cesarean Delivery - Part 1
Start Date: Oct 09, 2019 - Last Update: October 5, 2021
Conditions: Obstetric Pain, Postpartum Depression, Breastfeeding, Pain, Acute, Pain, Chronic, Obstetric Anesthesia Problems, Drug Effect, Opioid Use
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: EEG Characteristics in ECT
Start Date: Oct 01, 2019 - Last Update: July 19, 2019
Conditions: Electroconvulsive Therapy, Direct Current Electroencephalogram, Ketamine, Spreadind Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
Start Date: Sep 30, 2019 - Last Update: May 10, 2021
Conditions: Post-Traumatic Stress Disorders, Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted psychotherapy for the treatment of depression and anxiety associated with life-threatening illness
Start Date: Sep 27, 2019
Conditions: Depression in terminal illness (any palliative condition including malignant and non-malignant terminal illnesses), Anxiety in terminal illness (any palliative condition including malignant and non-malignan terminal illnesses)
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery
Start Date: Aug 22, 2019 - Last Update: March 17, 2021
Conditions: Major Depressive Disorder, Surgery, Orthopedic Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: dimethyltryptamine
Study Title: A phase 1/2 study of GH001 in patients with treatment-resistant depression
Start Date: Aug 21, 2019
Conditions: Treatment-resistant depression
Location(s): Netherlands
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Ketamine IV Classic Protocol : Five Years Follow up
Start Date: Aug 08, 2019 - Last Update: April 1, 2021
Conditions: Major Depressive Disorder, Drug Abuse, Medications, Relapse
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Endogenous Opioid Modulation by Ketamine
Start Date: Aug 01, 2019 - Last Update: January 28, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low dose individually-tailored subcutaneous ketamine infusion for the treatment of depression in palliative care patients
Start Date: Jul 29, 2019
Conditions: Major Depressive Disorder, Advanced life limiting illnesses
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
Start Date: Jul 17, 2019 - Last Update: February 23, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Mood Disorders With Suicidal Ideation
Start Date: Jul 01, 2019 - Last Update: March 2, 2021
Conditions: Depressive Disorder, Major, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine
Start Date: Jun 26, 2019 - Last Update: January 22, 2021
Conditions: Depressive Disorder, Treatment-Resistant
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
Start Date: Jun 25, 2019 - Last Update: September 8, 2021
Conditions: Bipolar Depression, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A pilot study on oral S-ketamine for depression and demoralisation in patients with advanced cancer receiving palliative care
Start Date: Jun 10, 2019 - Last Update:
Conditions: Depression and demoralisation, advanced (non-curable) cancer
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Study of Ketamine for Youth Depression
Start Date: May 20, 2019
Conditions: Major Depressive Disorder
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: The Role of HNKs in the Antidepressant Effect of Ketamine
Start Date: May 15, 2019 - Last Update: January 22, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine and Internalizing Disorders
Start Date: Apr 29, 2019
Conditions: Depression, Post-Traumatic Stress Disorder, Obsessive-Compulsive Disorder, Phobic Disorders
Location(s): New Zealand, Otago, Canterbury
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept
Start Date: Mar 11, 2019 - Last Update: September 30, 2021
Conditions: Depressive Disorder, Major
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression
Start Date: Mar 04, 2019 - Last Update: September 14, 2020
Conditions: Post Partum Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
Start Date: Mar 01, 2019 - Last Update: June 29, 2021
Conditions: Treatment Resistant Depression
Location(s): United States, Canada, Czechia, Denmark, Germany, Ireland, Netherlands, Portugal, Spain, United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine in anorexia nervosa
Start Date: Feb 09, 2019
Conditions: anorexia nervosa, depressive disorder, anxiety disorder, obessional disorder
Location(s): New Zealand, Dunedin, Otago
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression
Start Date: Feb 08, 2019 - Last Update: September 5, 2021
Conditions: Depressive Disorder, Treatment-Resistant
Location(s): United States, Spain
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Nitrous Oxide for the Treatment of Major Depressive Disorder
Start Date: Jan 22, 2019 - Last Update: April 22, 2020
Conditions: Depression, Major Depressive Disorder
Location(s): United States, Australia
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
Start Date: Jan 07, 2019 - Last Update: July 31, 2020
Conditions: Depressive Disorder, Major
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:
Start Date: Jan 03, 2019 - Last Update: September 10, 2021
Conditions: Major Depressive Disorder, Treatment Resistant Depression, Bipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Major Depressive Disorder
Start Date: Dec 28, 2018 - Last Update: April 25, 2019
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Co-induction for Patients With Major Depressive Disorder
Start Date: Dec 01, 2018 - Last Update: September 13, 2018
Conditions: Ketamine, Depression, Anesthesia
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
Start Date: Nov 29, 2018 - Last Update: September 2, 2021
Conditions: Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: Project PRIDE (Promoting Resilience In Discriminatory Environments)
Start Date: Nov 09, 2018 - Last Update: November 3, 2020
Conditions: Human Immunodeficiency Virus, Sexually Transmitted Infections, Anxiety, Depression, Substance Use Disorders
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: NRX101 Glx Biomarker Validation Study
Start Date: Nov 01, 2018 - Last Update: September 8, 2021
Conditions: Bipolar Depression, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Versus Electroconvulsive Therapy in Depression
Start Date: Oct 29, 2018 - Last Update: April 19, 2021
Conditions: Depressive Disorder, Major, Bipolar Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Evaluation of Schemes of Administration of Intravenous Ketamine in Depression
Start Date: Oct 01, 2018 - Last Update: September 10, 2019
Conditions: Treatment Resistant Depression
Location(s): Mexico
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study of Ketamine in Elderly Patients with Depression.
Start Date: Sep 24, 2018
Conditions: Depression
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Using a Low Dose of Ketamine vs. Active Placebo in Treating Severe Depression and Suicide
Start Date: Sep 10, 2018 - Last Update: September 19, 2018
Conditions: Major Depressive Disorder
Location(s): Taiwan
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Treatment Resistant MDD
Start Date: Sep 01, 2018 - Last Update: July 16, 2019
Conditions: Depressive Disorder, Major
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Psilocybin and Depression
Start Date: Sep 01, 2018 - Last Update: December 21, 2017
Conditions: Severe Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intranasal Esketamine to Maintain the Antidepressant Response to IV Racemic Ketamine
Start Date: Sep 01, 2018 - Last Update: April 23, 2021
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Trial Amsterdam (KETA), pilot
Start Date: Aug 20, 2018 - Last Update:
Conditions: (acute) suicidality, depression, personality disorders, substance use disorder. (acute) suïcidaliteit, depressie, persoonlijkheidsstoornissen, middelenmisbruik
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Comparative bioavailability assessment between 4 x 60 mg R107 tablets administered orally and 0.5mg/kg ketamine IV infusion over 40 minutes in healthy male and female participants under fasting conditions.
Start Date: Jul 18, 2018
Conditions: Depression, Anxiety
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care
Start Date: Jul 16, 2018 - Last Update: February 17, 2021
Conditions: Depression, Cancer, Palliative Care
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Comparative bioavailability assessment between R107 tablet and 60 mg ketamine IV solution administered orally in healthy male and female participants under fasting conditions.
Start Date: Jul 13, 2018
Conditions: Depression, Anxiety
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
Start Date: Jun 30, 2018 - Last Update: July 30, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Postpartum Perineal Pain After Obstetric Anal Sphincter Injuries
Start Date: Jun 27, 2018 - Last Update: January 6, 2021
Conditions: Pain, Postpartum Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse
Start Date: May 01, 2018 - Last Update: July 13, 2021
Conditions: Suicidal Ideation, Depression, Alcohol Abuse
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of Ketamine in Depressive Symptoms of Elderly Patients With Visual Impairment.
Start Date: Apr 15, 2018 - Last Update: February 28, 2019
Conditions: Depression in Old Age, Ketamine
Location(s): Mexico
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms
Start Date: Apr 09, 2018
Conditions: Major Depressive Disorder
Location(s): United Kingdom
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
Start Date: Apr 03, 2018 - Last Update: January 21, 2020
Conditions: Depressive Disorder
Location(s): Brazil
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Efficacy and Safety of TAK-653 in Treatment-Resistant Depression
Start Date: Feb 15, 2018 - Last Update: February 22, 2018
Conditions: Treatment-Resistant Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Respiratory Depression During an Analgosedation Combining Remifentanil and Ketamine in TCI for Oocyte Retrieval
Start Date: Feb 12, 2018 - Last Update: March 13, 2018
Conditions: Oocyte Retrieval, Sedation, Conscious, Ventilatory Depression
Location(s): Belgium
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: Effects of an 8-day Advanced Meditation, Samyama on Physical, Psychological and Spiritual Wellbeing ,and Associated Neural Mechanisms
Start Date: Jan 19, 2018 - Last Update: August 20, 2021
Conditions: Mental Health Wellness 1, Happiness, Depression, Consciousness, Level Altered, Ecstasy, Dietary Habits, Stress, Inflammatory Bowel Diseases
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Sequential Therapy for the Treatment of Severe Bipolar Depression.
Start Date: Jan 15, 2018 - Last Update: May 25, 2021
Conditions: Bipolar Depression, Suicidal Ideas, Suicidal Ideation, Suicide, Attempted
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Start Date: Jan 05, 2018 - Last Update: January 7, 2021
Conditions: Distress, Depression, Grief
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intravenous Ketamine Plus Neurocognitive Training for Depression
Start Date: Dec 01, 2017 - Last Update: October 1, 2021
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine
Start Date: Nov 30, 2017 - Last Update: August 16, 2018
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression
Start Date: Nov 23, 2017 - Last Update: August 7, 2018
Conditions: Perinatal Depression, Ketamine, Cesarean Delivery, Postpartum Depression
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effects of S-ketamine on brain activation in healthy women, healthy women prone to depression and fibromyalgia patients.
Start Date: Nov 07, 2017 - Last Update:
Conditions: Ketamine, fMRI, fibromyalgia, depression
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy
Start Date: Oct 15, 2017 - Last Update: August 10, 2021
Conditions: Anesthesia, General Anesthesia, Analgesics, Opioid, Postoperative Complications, Pathologic Processes, Physiologic Effects of Drugs, Narcotics, Analgesics, Sleep Disordered Breathing, Obstructive Sleep Apnea of Child, Tonsillectomy, Respiratory Depression, Dexmedetomidine, Ketamine, Lidocaine, Gabapentin, Pulse Oximetry
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)
Start Date: Sep 14, 2017 - Last Update: July 24, 2020
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: ECT With Ketamine Anesthesia vs High Intensity Ketamine With ECT Rescue for Treatment-Resistant Depression
Start Date: Sep 01, 2017 - Last Update: August 10, 2021
Conditions: Treatment Resistant Depression, Ketamine
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Single dose ketamine pharmacokinetic-pharmacodynamic relationships in healthy volunteers
Start Date: Sep 01, 2017
Conditions: major depressive disorder, post traumatic stress disorder, obsessive compulsive disorder, generalized anxiety disorder, social phobia
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: psilocybin
Study Title: Effects of Psilocybin in Major Depressive Disorder
Start Date: Aug 10, 2017 - Last Update: December 11, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as an adjunctive therapy for Major Depression - a randomised controlled pilot trial: The KARMA-Dep Trial
Start Date: Jul 24, 2017
Conditions: Depression
Location(s): Ireland
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Ketamine and Postoperative Depressive Symptom-PASSION
Start Date: Jul 05, 2017 - Last Update: July 7, 2020
Conditions: Ketamine; Depressive Symptom; Neurosurgery; Perioperative Period
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
Start Date: Jun 01, 2017 - Last Update: April 6, 2021
Conditions: Major Depression, Bipolar I Disorder, Bipolar II Disorder, Unipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
Start Date: May 25, 2017 - Last Update: September 9, 2021
Conditions: Healthy Volunteer, Major Depressive Disorder, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Dexamethasone and Ketamine on Change of Postoperative Mood
Start Date: May 02, 2017 - Last Update: June 21, 2017
Conditions: Depressive Symptoms
Location(s): Korea, Republic of
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Investigation of Antidepressant Efficacy of Oral Ketamine Treatment
Start Date: Apr 24, 2017 - Last Update: September 3, 2019
Conditions: Major Depressive Episode
Location(s): Austria
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
Start Date: Apr 07, 2017 - Last Update: August 18, 2021
Conditions: Treatment Resistant Depression, Electroconvulsive Therapy, ECT, Ketamine, Psychiatric Disorder, Depression, Major Depressive Disorder, Major Depressive Episode, Unipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine and Nitroprusside for Depression
Start Date: Feb 14, 2017 - Last Update: July 2, 2020
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Open Label Ketamine Treatment for Major Depressive Disorder in Veterans
Start Date: Jan 31, 2017 - Last Update: October 6, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant Depression
Start Date: Jan 01, 2017 - Last Update: February 5, 2020
Conditions: Depressive Disorder, Major
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer
Start Date: Dec 20, 2016 - Last Update: November 6, 2018
Conditions: Cancer, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The UTHealth Ketamine Project
Start Date: Nov 07, 2016 - Last Update: November 24, 2020
Conditions: Treatment Resistant Depression, Major Depressive Disorder, Bipolar Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Reversal of opioid-induced respiratory depression (OIRD) by ketamine in healthy volunteers
Start Date: Oct 21, 2016 - Last Update:
Conditions: ketamine; opioid-induced respiratory depression
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients
Start Date: Oct 14, 2016 - Last Update: August 31, 2020
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Orale ketamine als aanvullende behandeling bij patiënten met een therapieresistente depressie
Start Date: Oct 01, 2016 - Last Update:
Conditions: Treatment-resistant major depressive disorder, therapie resistente depressie
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: A single and multiple dose safety and tolerability study of oral ketamine in healthy volunteer and patients with a history of depression or anxiety.
Start Date: Sep 29, 2016
Conditions: Depression, Anxiety
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
Start Date: Sep 08, 2016 - Last Update: January 8, 2021
Conditions: Depression
Location(s): France
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Neurocognitive Features of Patients With Treatment-Resistant Depression
Start Date: Sep 01, 2016 - Last Update: March 11, 2020
Conditions: Treatment Resistant Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)
Start Date: Sep 01, 2016 - Last Update: April 24, 2018
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression
Start Date: Sep 01, 2016 - Last Update: October 21, 2016
Conditions: Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A randomised controlled trial of oral S-ketamine as add-on medication for patients with treatment-resistant major depressive disorder
Start Date: Aug 30, 2016
Conditions: Treatment resistant major depressive disorder
Location(s): Netherlands
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers
Start Date: Aug 15, 2016 - Last Update: November 6, 2018
Conditions: Head and Neck Cancer, Pancreatic Cancer, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study to Decrease Suicidal Thinking Using Ketamine
Start Date: Aug 01, 2016 - Last Update: September 3, 2019
Conditions: Depression, Suicide
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Emergency Ketamine Treatment of Suicidal Ideation
Start Date: Aug 01, 2016 - Last Update: August 5, 2016
Conditions: Depression, Suicidal Ideation, Suicidal Impulses
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Adult Depression Study
Start Date: Jul 22, 2016
Conditions: Major Depressive Disorder
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Physiological and Cognitive Biomarkers for Ketamine's Antidepressant Effects
Start Date: Jul 01, 2016 - Last Update: April 23, 2018
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression
Start Date: Jun 01, 2016 - Last Update: May 13, 2016
Conditions: Treatment Resistant Depression
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter
Start Date: May 01, 2016 - Last Update: October 15, 2018
Conditions: Depression, Ketamine
Location(s): Austria
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
Start Date: May 01, 2016 - Last Update: September 7, 2018
Conditions: Major Depressive Disorder, Alcohol Use Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia
Start Date: Apr 01, 2016 - Last Update: June 28, 2021
Conditions: Depression, Delirium, Seizures, Cognitive Disorders
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intra-nasal vs. Intra-venous Ketamine Administration
Start Date: Apr 01, 2016 - Last Update: October 28, 2020
Conditions: Major Depressive Disorder
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Imaging SV2A in Mood Disorders
Start Date: Apr 01, 2016 - Last Update: March 3, 2021
Conditions: Major Depressive Disorder, Post-Traumatic Stress Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Depression: An MRI Study
Start Date: Mar 01, 2016 - Last Update: April 16, 2019
Conditions: Depression, Anxious Depression, Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects
Start Date: Mar 01, 2016 - Last Update: July 16, 2020
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Anesthesia for Improvement of Depression in ECT
Start Date: Mar 01, 2016 - Last Update: June 6, 2018
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: What is the difference in the safety of Ketamine versus Propofol when used to sedate Acute Psychiatric/ Psychotic Patients who require Aeromedical Retrieval?
Start Date: Jan 09, 2016
Conditions: Suicidal Ideation, Depression, Acute Psychosis, Schizophrenia, Attempted Suicide, Post Natal Depression, Self Harm, Personality Disorder, Bipolar Disorder
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: A randomised controlled study of an N-Methyl-D-Aspartate antagonist in major depression
Start Date: Jan 08, 2016
Conditions: Depression, Major depressive disorder
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.
Start Date: Jan 01, 2016 - Last Update: July 26, 2017
Conditions: Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder, Bipolar Depression, Suicidal Ideation
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms
Start Date: Dec 01, 2015 - Last Update: February 15, 2018
Conditions: Depression, Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Relapse Prevention in Recurrent Depressive Disorder
Start Date: Dec 01, 2015 - Last Update: January 13, 2020
Conditions: Depression, Relapse, Recurrent Depressive Disorder, Major Depressive Disorder
Location(s): Ireland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Neurobiology of Suicide
Start Date: Dec 01, 2015 - Last Update: September 8, 2021
Conditions: Healthy Volunteers, Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder
Start Date: Oct 14, 2015 - Last Update: December 6, 2019
Conditions: Major Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Treatment Resistant Late-Life Depression
Start Date: Oct 01, 2015 - Last Update: August 9, 2021
Conditions: Treatment Resistant Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Infusion for Adolescent Depression and Anxiety
Start Date: Oct 01, 2015 - Last Update: July 14, 2020
Conditions: Major Depressive Disorder, Anxiety Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy
Start Date: Oct 01, 2015 - Last Update: April 28, 2021
Conditions: Depressive Disorder
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder
Start Date: Sep 01, 2015 - Last Update: February 19, 2018
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression
Start Date: Aug 01, 2015 - Last Update: August 29, 2019
Conditions: Treatment Resistant Depression, Major Depressive Disorder, Severe Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intranasal Ketamine for Late-Life Depression and Suicidal Ideation
Start Date: Jul 01, 2015 - Last Update: March 3, 2017
Conditions: Depression, Suicide, Suicidal Ideation
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Heart Rate Variability in Depression
Start Date: Jul 01, 2015 - Last Update: September 20, 2019
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Spreading Depolarization and Ketamine Suppression
Start Date: Jul 01, 2015 - Last Update: October 25, 2017
Conditions: Cortical Spreading Depolarization, Cortical Spreading Depression, Subarachoid Hemorrhage, Traumatic Brain Injury
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Perioperative Ketamine to Reduce Postoperative Delirium and Depression - The RECOGNISED Study
Start Date: May 06, 2015
Conditions: Depression , Delirium, Postoperative Cognitive Dysfunction
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Ketamine Infusions for PTSD and Treatment-Resistant Depression
Start Date: May 01, 2015 - Last Update: May 14, 2019
Conditions: Depressive Disorder, Treatment-Resistant, Stress Disorders, Post-Traumatic
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome
Start Date: Apr 20, 2015 - Last Update: July 2, 2021
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Studying the antidepressant effects of intravenous ketamine in patients with major depressive disorder
Start Date: Apr 06, 2015
Conditions: Major Depressive Disorder
Location(s): Singapore
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression
Start Date: Apr 01, 2015 - Last Update: May 11, 2021
Conditions: Treatment-resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Depression Relapse Prevention Following ECT
Start Date: Apr 01, 2015 - Last Update: May 6, 2021
Conditions: Depression
Location(s): Ireland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Trial for the Treatment of Depression
Start Date: Mar 01, 2015 - Last Update: March 27, 2015
Conditions: Unipolar Depression
Location(s): Australia
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder
Start Date: Feb 01, 2015 - Last Update: December 19, 2019
Conditions: Depressive Disorder, Major
Location(s): Sweden
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine
Start Date: Feb 01, 2015 - Last Update: March 1, 2017
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Assessing the subjective intensity of oral psilocybin in patients with treatment-resistant depression: A Pilot Study
Start Date: Jan 07, 2015
Conditions: Major depressive disorder
Location(s): United Kingdom
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine
Start Date: Jan 01, 2015 - Last Update: March 20, 2019
Conditions: Major Depressive Disorder
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy
Start Date: Jan 01, 2015 - Last Update: December 2, 2014
Conditions: Depressive Symptoms, Impaired Cognition, Electroconvulsive Therapy
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)
Start Date: Dec 01, 2014 - Last Update: June 19, 2018
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy
Start Date: Oct 01, 2014 - Last Update: March 16, 2020
Conditions: Pain, Postoperative Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine in Adolescents With Treatment-Resistant Depression
Start Date: Sep 01, 2014 - Last Update: January 27, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Depression and Suicide Risk
Start Date: Sep 01, 2014 - Last Update: August 11, 2017
Conditions: Depression, Suicide
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine's Actions on Rumination Mechanisms as an Antidepressant
Start Date: Sep 01, 2014 - Last Update: December 7, 2020
Conditions: Remission in Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Infusions for Major Depression Disorder
Start Date: Aug 01, 2014 - Last Update: August 29, 2014
Conditions: Depressive Disorder, Major
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy
Start Date: Jul 01, 2014 - Last Update: October 20, 2014
Conditions: Depressive Disorder
Location(s): Turkey
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Biomarkers of Fast Acting Therapies in Major Depression
Start Date: Jun 01, 2014 - Last Update: August 28, 2019
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
Start Date: May 01, 2014 - Last Update: September 21, 2016
Conditions: Depressive Disorder, Treatment-Resistant
Location(s): Mexico
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Alcohol (in Treatment-Resistant Depression)
Start Date: Apr 23, 2014 - Last Update: July 7, 2020
Conditions: Magnetic Resonance Imaging, Major Depression, Alcoholism
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ayahuasca
Study Title: Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression
Start Date: Feb 01, 2014 - Last Update: February 17, 2017
Conditions: Major Depression
Location(s): Brazil
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder
Start Date: Feb 01, 2014 - Last Update: January 27, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Evaluation of the Pharmacokinetics of Sublingual IPX237 in Healthy Volunteers
Start Date: Jan 07, 2014
Conditions: Depression
Location(s): Australia, United States of America
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression
Start Date: Jan 01, 2014 - Last Update: April 2, 2020
Conditions: Suicidal Ideation, Major Depressive Disorder, Healthy Participants
Location(s): Israel
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Use in Electroconvulsive Therapy
Start Date: Jan 01, 2014 - Last Update: March 19, 2015
Conditions: Depression
Location(s): Brazil
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The Effects of Ketamine on Respiratory Stimulation and Transpulmonary Pressures
Start Date: Jan 01, 2014 - Last Update: February 25, 2021
Conditions: Mechanical Ventilation, Airway Patency, Respiratory Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients
Start Date: Dec 01, 2013 - Last Update: September 14, 2018
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Evaluation of the Pharmacokinetics of IPX237 Formulations in Healthy Volunteers
Start Date: Sep 12, 2013
Conditions: Depression
Location(s): Australia, United States of America
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Ketamine for Suicidality in Bipolar Depression
Start Date: Sep 01, 2013 - Last Update: March 11, 2020
Conditions: Bipolar Disorder, Major Depressive Episode, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy
Start Date: Sep 01, 2013 - Last Update: September 13, 2017
Conditions: Treatment Resistant Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population
Start Date: Sep 01, 2013 - Last Update: March 17, 2015
Conditions: Depressive Disorder,, Treatment-Resistant Depression
Location(s): Mexico
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Plus Lithium in Treatment-Resistant Depression
Start Date: Jul 01, 2013 - Last Update: July 31, 2018
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling
Start Date: Jul 01, 2013 - Last Update: September 8, 2021
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: An Open Prospective Trial of IV Ketamine in Suicidal Adolescents
Start Date: Jun 01, 2013 - Last Update: January 29, 2014
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression
Start Date: Jun 01, 2013 - Last Update: June 30, 2015
Conditions: Depressive Disorder
Location(s): Belgium, France, Netherlands, Spain
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Action of Ketamine in Treatment-Resistant Depression
Start Date: May 01, 2013 - Last Update: June 26, 2018
Conditions: Treatment-resistant Depression
Location(s): Canada
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder
Start Date: Jan 01, 2013 - Last Update: April 20, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Trial of Ketamine and Lithium Therapy in Bipolar Depression
Start Date: Jan 01, 2013 - Last Update: March 9, 2020
Conditions: Bipolar Depression
Location(s):
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: ECT and Memantine.
Start Date: Dec 01, 2012 - Last Update:
Conditions: Electroconvulsive therapy Cognitive side effects Memantine Electroconvulsieve therapie Cognitieve bijwerkingen Memantine Depression Depressie
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Nitrous Oxide as Treatment for Major Depression - a Pilot Study
Start Date: Nov 01, 2012 - Last Update: January 27, 2020
Conditions: Depression, Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study of Ketamine in Patients With Treatment-resistant Depression
Start Date: Aug 06, 2012 - Last Update: June 2, 2020
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: PET Imaging of mGLuR5 With Drug Challenge
Start Date: Jun 01, 2012 - Last Update: April 21, 2017
Conditions: Major Depressive Disorder, Post-Traumatic Stress Disorder (PTSD)
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine in the Treatment of Suicidal Depression
Start Date: Jun 01, 2012 - Last Update: March 11, 2020
Conditions: Major Depressive Disorder, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Treatment of Suicidal Ideation With Intravenous Ketamine Infusion
Start Date: May 01, 2012 - Last Update: May 15, 2017
Conditions: Depression, Suicidal Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Treatment Resistant Depression (Pilot)
Start Date: Apr 01, 2012 - Last Update: October 6, 2021
Conditions: Depressive Disorder, Treatment-Resistant
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Infusion for Treatment-resistant Major Depressive Disorder
Start Date: Apr 01, 2012 - Last Update: April 20, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine in treatment resistant major depression (TRD)
Start Date: Mar 05, 2012
Conditions: Therapy resistant depression
Location(s): Germany
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: ketamine
Study Title: Ketamine for Depression and Alcohol Dependence
Start Date: Mar 01, 2012 - Last Update: March 9, 2020
Conditions: Depression, Alcohol Dependence
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
Start Date: Mar 01, 2012 - Last Update: February 24, 2017
Conditions: Major Depressive Disorder
Location(s): France
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effects of Sevoflurane and Ketamine on QT in Electroconvulsive Therapy
Start Date: Feb 01, 2012 - Last Update: June 6, 2013
Conditions: Major Depression, Electroconvulsive Therapy
Location(s): Turkey
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study of Ketamine as an Antidepressant in Major Depressive Disorder
Start Date: Feb 01, 2012 - Last Update: May 4, 2012
Conditions: Major Depressive Disorder
Location(s): China
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine in the Treatment of Depression
Start Date: Feb 01, 2012 - Last Update: December 10, 2019
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: Characterization of the Prosocial and Prosexual Effects of GHB
Start Date: Feb 01, 2012 - Last Update: July 29, 2019
Conditions: Depressive Disorder, Major, Bipolar Disorder, Autistic Disorder
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Subanesthetic IV Bolus Ketamine in the Treatment of Acute Depression
Start Date: Dec 01, 2011 - Last Update: March 4, 2015
Conditions: Acute Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Intranasal Ketamine in Treatment-Resistant Depression
Start Date: Oct 01, 2011 - Last Update: February 8, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: A Study of Ketamine as an Antidepressant
Start Date: Sep 01, 2011 - Last Update: February 22, 2013
Conditions: Major Depressive Episode
Location(s): Australia
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: MRI Studies of Emotion in Depression
Start Date: Jul 15, 2011 - Last Update: April 6, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Anesthesia in Electroconvulsive Therapy
Start Date: May 01, 2011 - Last Update: August 8, 2013
Conditions: Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Rapid depression treatment in cancer patients
Start Date: Mar 23, 2011
Conditions: Major depressive disorder, Cancer
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: The Use of Ketamine as an Anaesthetic During Electroconvulsive Therapy
Start Date: Mar 01, 2011 - Last Update: September 8, 2016
Conditions: Depression
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Neuromodulation to Facilitate the Effect of Ketamine
Start Date: Jan 01, 2011 - Last Update: March 22, 2013
Conditions: Depression, Chronic Pain, Substance Abuse
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression
Start Date: Nov 01, 2010 - Last Update: May 22, 2017
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Study of Depression-Ketamine-Brain Function
Start Date: Jun 01, 2010 - Last Update: December 7, 2015
Conditions: Major Depression
Location(s): Switzerland
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression
Start Date: Jun 01, 2010 - Last Update: August 10, 2017
Conditions: Unipolar Depression, Bipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression
Start Date: Apr 01, 2010 - Last Update: August 30, 2013
Conditions: Major Depression, Bipolar Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine for Low Mood States in the ER
Start Date: Apr 01, 2010 - Last Update: August 24, 2020
Conditions: Depression, Suicide Ideation
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: mdma
Study Title: Fluoxetine and the developing brain.
Start Date: Feb 01, 2010 - Last Update:
Conditions: Major depression/depressie, SSRI, fluoxetine, serotonine, development/ontwikkeling
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Pilot study for the rapid alleviation of depression in depressed alcohol dependent persons using ketamine
Start Date: Jan 09, 2010
Conditions: depression, alcohol dependence
Location(s): New Zealand
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: The effect of ketamine and methadon on healthy volunteers with special focus on painscore, sedation, ventilatory depression and change of pupil diameter.
Start Date: Jan 02, 2010 - Last Update:
Conditions: analgesia respiratory depression pijnstilling analgesie ademhalingsdepressie
Location(s): Netherlands
Source: trialregister.nl
short summary

Entheogen: ketamine
Study Title: Study Where Pharmaco Magnetic Resonance Imaging (MRI) Effects of AZD6765 Will be Compared to Placebo in Depressive Male and Female Subjects
Start Date: Dec 01, 2009 - Last Update: October 13, 2014
Conditions: Depression
Location(s): United Kingdom
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
Start Date: Jan 01, 2009 - Last Update: February 14, 2018
Conditions: Stress Disorders, Post-Traumatic, PTSD, Depression, Anxiety Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Optimization of IV Ketamine for Treatment Resistant Depression
Start Date: Nov 01, 2008 - Last Update: January 31, 2014
Conditions: Major Depressive Disorder (MDD), Treatment Resistant Depression (TRD)
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine as an Anaesthetic Agent in Electroconvulsive Therapy (ECT)
Start Date: Apr 01, 2008 - Last Update: March 29, 2013
Conditions: Major Depressive Episode
Location(s): Australia
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Ketamine Frequency Treatment for Major Depressive Disorder
Start Date: Mar 01, 2008 - Last Update: June 6, 2011
Conditions: Treatment Resistant Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Continuation Ketamine in Major Depression
Start Date: Oct 01, 2007 - Last Update: May 23, 2014
Conditions: Major Depressive Disorder
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: psilocybin
Study Title: Psychopharmacology of Psilocybin in Cancer Patients
Start Date: Apr 01, 2007 - Last Update: July 19, 2018
Conditions: Depressive Symptoms, Anxiety, Cancer
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Altered breathing with postoperative pain relief
Start Date: Jan 06, 2007
Conditions: Obesity, Respiratory Depression, Postoperative analgesia
Location(s): Australia
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
Start Date: Dec 01, 2006 - Last Update: July 31, 2019
Conditions: Major Depression
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Effect of intra-operative sedation with low-doses of S-Ketamine on depression in the elderly: randomized double-blind controlled trial
Start Date: May 20, 2006
Conditions: Mental Depression
Location(s): Brazil, Distrito Federal
Source: anzctr.org.au
short summary

Entheogen: ketamine
Study Title: Rapid Antidepressant Effects of Ketamine in Major Depression
Start Date: Jul 26, 2004 - Last Update: October 12, 2018
Conditions: Depression, Mood Disorders, Major Depresssion
Location(s): United States
Source: clinicaltrials.gov
short summary

Entheogen: ketamine
Study Title: Clinical and neurobiological predictors of response to ketamine: towards personalized treatment of depression
Start Date:
Conditions: Moderate to severe depression without psychotic symptoms
Location(s): Czech Republic
Source: www.clinicaltrialsregister.eu
short summary

Entheogen: psilocybin
Study Title: The safety and efficacy of psilocybin as an adjunctive therapy in participants with treatment-resistant depression
Start Date:
Conditions: treatment resistant depression
Location(s): Ireland(Restarted)
Source: www.clinicaltrialsregister.eu
short summary



Total execution time in seconds: 0.072468996047974